CHICAGO—Patients with oropharyngeal cancer pose no risk of passing HPV infection to their spouses or partners — according findings presented at the 2013 meeting of the American Society of Clinical Onc
CHICAGO—Patients with oropharyngeal cancer pose no risk of passing HPV infection to their spouses or partners — according findings presented at the 2013 meeting of the American Society of Clinical Oncology — even though their cancers may have been caused by this virus. This conclusion is from the Human Oral Papillomavirus Transmission in Partners over Time (HOTPSOT) study confirming that couples in long-term relationships do not need to change their intimacy or sexual behaviour because of a cancer diagnosis. Dr Gypsyamber D’Souza from Johns Hopkins Bloomberg School of Public Health in Baltimore MD discussed their findings with Peter Goodwin.
Related Episodes
Jefferson DeKloe BSc: Big US Study Confirms Benefit of HPV Vaccination for Boys as Well as Girls
The cancer prevention benefit of vaccination against the human papilloma virus cancer prevent are slowly accruing thanks to European, American and other population-based studies. I’m Peter Goodwin wi
Luis Paz-Ares MD PhD: Longer Survival Among Patients with Extensive Stage Small Cell Lung Cancer Treated with Lurbinectedin Maintenance —ASCO 2025
Luis G Paz-Ares MD PhD discdusses the addition of lurbinectedin as maintenance therapy for extensive stage small cell lung cancer (SCLC)
Frank A Sinicrope MD: Stage 3 Colon Cancer with Deficient Mismatch Repair: Big Gains from Atezolizumab Added to Standard Chemotherapy
An interview with: Frank A Sinicrope, MD, Medical Oncologist, Mayo Clinic, Rochester, Minnesota. CHICAGO —Big gains in survival have been reported among patients with stage three, node-positive colon